Cytek Biosciences Inc. (CTKB)
undefined
undefined%
At close: undefined
6.21
0.32%
After-hours Dec 13, 2024, 04:00 PM EST

Company Description

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis.

The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils.

In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools.

The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations.

It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries.

The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015.

Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Cytek Biosciences Inc.
Cytek Biosciences Inc. logo
Country United States
IPO Date Jul 23, 2021
Industry Medical - Devices
Sector Healthcare
Employees 645
CEO Dr. Wenbin Jiang Ph.D.

Contact Details

Address:
47215 Lakeview Boulevard
Fremont, California
United States
Website https://cytekbio.com

Stock Details

Ticker Symbol CTKB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001831915
CUSIP Number 23285D109
ISIN Number US23285D1090
Employer ID 47-2547526
SIC Code 3826

Key Executives

Name Position
Dr. Wenbin Jiang Ph.D. President, Chief Executive Officer & Chairman of the Board
Dr. Ming Yan Ph.D. Chief Technology Officer & Director
Valerie T. Barnett J.D. Chief Legal Officer & Corporate Secretary
William D. McCombe Chief Financial Officer
Dr. Allen B. Poirson Ph.D. Senior Vice President of Business & Corporate Development
Dr. Philippe Busque Ph.D. Senior Vice President of Global Sales & Services
Patrik Sebastian Jeanmonod Head of Corporate Development Analytics

Latest SEC Filings

Date Type Title
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 20, 2024 4 Filing
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership b...
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 07, 2024 10-Q Quarterly Report
Nov 05, 2024 8-K Current Report